-
Impact of reimbursement systems on patient care – a systematic review of systematic reviews Health Economics Review (IF 2.118) Pub Date : 2024-03-16 Eva Wagenschieber, Dominik Blunck
There is not yet sufficient scientific evidence to answer the question of the extent to which different reimbursement systems influence patient care and treatment quality. Due to the asymmetry of information between physicians, health insurers and patients, market-based mechanisms are necessary to ensure the best possible patient care. The aim of this study is to investigate how reimbursement systems
-
Correction: Universal health coverage in the context of population ageing: catastrophic health expenditure and unmet need for healthcare Health Economics Review (IF 2.118) Pub Date : 2024-03-11 Shohei Okamoto, Mizuki Sata, Megumi Rosenberg, Natsuko Nakagoshi, Kazuki Kamimura, Kohei Komamura, Erika Kobayashi, Junko Sano, Yuzuki Hirazawa, Tomonori Okamura, Hiroyasu Iso
Correction to: Health Econ Rev 14, 8 (2024) https://doi.org/10.1186/s13561-023-00475-2 Following the publication of the original article [1], the license copyright has been corrected to CC BY 3.0 IGO instead of Creative Commons Attribution 4.0 International License. The full correct copyright line should read as below: © World Health Organization 2024. Open Access This article is licensed under the
-
Catastrophic health expenditures: a disproportionate risk in uninsured ethnic minorities with diabetes Health Economics Review (IF 2.118) Pub Date : 2024-03-06 Sebastian Linde, Leonard E. Egede
Chargemaster prices are the list prices that providers and health systems assign to each of their medical services in the US. These charges are often several factors of magnitude higher than those extended to individuals with either private or public insurance, however, these list prices are billed in full to uninsured patients, putting them at increased risk of catastrophic health expenditures (CHE)
-
End-of-life expenditure on health care for the older population: a scoping review Health Economics Review (IF 2.118) Pub Date : 2024-03-01 Ewa Kocot, Azzurra Ferrero, Shibu Shrestha, Katarzyna Dubas-Jakóbczyk
The existing evidence shows that the pattern of health expenditure differs considerably between people at the end-of-life and people in other periods of their lives. The awareness of these differences, combined with a detailed analysis of future mortality rates is one of the key pieces of information needed for health spending prognoses. The general objective of this review was to identify and map
-
Timing of preventive behavior in the case of a new and evolving health risk: the case of COVID-19 vaccination Health Economics Review (IF 2.118) Pub Date : 2024-02-27 Deeksha Gupta, Caroline Rudisill
Time preferences for preventive behavior under novel risks and uncertain contexts may differ from timing preferences related to familiar risks. Therefore, it is crucial to examine drivers of preventative health behavior timing in light of new health risks. Using the case of COVID-19, we examine factors affecting vaccination timing plans when vaccines were widely available in the European Union (EU)
-
Public health spending in Sub-Saharan Africa: exploring transmission mechanisms using the latent growth curve mediation model Health Economics Review (IF 2.118) Pub Date : 2024-02-19 Wa Ntita Serge Kabongo, Josue Mbonigaba
In response to the imperatives of universal health coverage, structural factors that may hinder the effectiveness of increased spending in sub-Saharan Africa (SSA) need attention. This study assessed the mediating role of these factors in domestic general government health expenditure (DGGHE) effects to propose solutions for improving population health outcomes (PHO). The analysis used the Latent Growth
-
The economic costs of orthopaedic services: a health system cost analysis of tertiary hospitals in a low-income country Health Economics Review (IF 2.118) Pub Date : 2024-02-17 Pakwanja Twea, David Watkins, Ole Frithjof Norheim, Boston Munthali, Sven Young, Levison Chiwaula, Gerald Manthalu, Dominic Nkhoma, Peter Hangoma
Traumatic injuries are rising globally, disproportionately affecting low- and middle-income countries, constituting 88% of the burden of surgically treatable conditions. While contributing to the highest burden, LMICs also have the least availability of resources to address this growing burden effectively. Studies on the cost-of-service provision in these settings have concentrated on the most common
-
Cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing–remitting multiple sclerosis: a systematic review Health Economics Review (IF 2.118) Pub Date : 2024-02-16 Nasrin Abulhasanbeigi Gallehzan, Majid Khosravi, Khosro Jamebozorgi, Nazanin Mir, Habib Jalilian, Samira Soleimanpour, Saeed Hoseini, Aziz Rezapour, Abbas Eshraghi
Multiple sclerosis (MS) is a chronic, autoimmune, and inflammatory disease. The economic burden of MS is substantial, and the high cost of Disease-modifying drugs (DMDs) prices are the main drivers of healthcare expenditures. We conducted a systematic review of studies evaluating the cost-utility and cost-effectiveness of DMDs for relapsing–remitting multiple sclerosis (RRMS). Searches were conducted
-
Evaluating the costs of adverse drug events in hospitalized patients: a systematic review Health Economics Review (IF 2.118) Pub Date : 2024-02-08 Maxime Durand, Christel Castelli, Clarisse Roux-Marson, Jean-Marie Kinowski, Géraldine Leguelinel-Blache
Adverse drug events (ADEs) are not only a safety and quality of care issue for patients, but also an economic issue with significant costs. Because they often occur during hospital stays, it is necessary to accurately quantify the costs of ADEs. This review aimed to investigate the methods to calculate these costs, and to characterize their nature. A systematic literature review was conducted to identify
-
Impact of 2009 American Recovery and Reinvestment Act (ARRA) health center investments on disadvantaged neighborhoods after recession Health Economics Review (IF 2.118) Pub Date : 2024-01-31 Elizabeth L. Tung, Nour Asfour, Joshua D. Bolton, Elbert S. Huang, Calvin Zhang, Luc Anselin
Federally qualified health centers (FQHCs) are integral to the U.S. healthcare safety net and uniquely situated in disadvantaged neighborhoods. The 2009 American Recovery and Reinvestment Act (ARRA) invested $2 billion in FQHC stimulus during the Great Recession; but it remains unknown whether this investment was associated with extended benefits for disadvantaged neighborhoods. We used a propensity-score
-
Universal health coverage in the context of population ageing: catastrophic health expenditure and unmet need for healthcare Health Economics Review (IF 2.118) Pub Date : 2024-01-30 Shohei Okamoto, Mizuki Sata, Megumi Rosenberg, Natsuko Nakagoshi, Kazuki Kamimura, Kohei Komamura, Erika Kobayashi, Junko Sano, Yuzuki Hirazawa, Tomonori Okamura, Hiroyasu Iso
Universal health coverage means that all people can access essential health services without incurring financial hardship. Even in countries with good service coverage and financial protection, the progress towards universal health coverage may decelerate or be limited with respect to the growing older population. This study investigates the incidence/prevalence, determinants, and consequences of catastrophic
-
Research trends in contemporary health economics: a scientometric analysis on collective content of specialty journals Health Economics Review (IF 2.118) Pub Date : 2024-01-25 Clara C. Zwack, Milad Haghani, Esther W. de Bekker-Grob
Health economics is a thriving sub-discipline of economics. Applied health economics research is considered essential in the health care sector and is used extensively by public policy makers. For scholars, it is important to understand the history and status of health economics—when it emerged, the rate of research output, trending topics, and its temporal evolution—to ensure clarity and direction
-
An analysis of the trend towards universal health coverage and access to healthcare in Morocco Health Economics Review (IF 2.118) Pub Date : 2024-01-20 Tarek Drissi Bouzaidi, Aziz Ragbi
We aim in this study to investigate the association between access to health care services and various components of universal health coverage in Morocco, controlling for socioeconomic, demographic, and cultural factors. The study employed a logistic regression method to model the relationship between access to health care as binary outcome variable and health coverage, using the longitudinal data
-
Mechanical ventilation as a major driver of COVID-19 hospitalization costs: a costing study in a German setting Health Economics Review (IF 2.118) Pub Date : 2024-01-16 Leslie R. Zwerwer, Jan Kloka, Simon van der Pol, Maarten J. Postma, Kai Zacharowski, Antoinette D. I. van Asselt, Benjamin Friedrichson
While COVID-19 hospitalization costs are essential for policymakers to make informed health care resource decisions, little is known about these costs in western Europe. The aim of the current study is to analyze these costs for a German setting, track the development of these costs over time and analyze the daily costs. Administrative costing data was analyzed for 598 non-Intensive Care Unit (ICU)
-
Cost-effectiveness analysis of parenteral iron therapy compared to oral iron supplements in managing iron deficiency anemia among pregnant women Health Economics Review (IF 2.118) Pub Date : 2024-01-02 Somen Saha, Devang Raval, Komal Shah, Deepak Saxena
This study compared the clinical efficacy and cost-effectiveness of parenteral iron, using intravenous iron sucrose (IVIS) therapy against the standard regimen of oral iron (OI) therapy for managing iron-deficiency anemia (IDA) among pregnant women in a natural primary care setting in Gujarat. A prospective cost-effectiveness study was conducted in natural programme setting wherein 188 pregnant women
-
Upcoding in medicare: where does it matter most? Health Economics Review (IF 2.118) Pub Date : 2024-01-02 Keith A. Joiner, Jianjing Lin, Juan Pantano
Upcoding in Medicare has been a topic of interest to economists and policy makers for nearly 40 years. While upcoding is generally understood as “billing for services at higher level of complexity than the service actually pro- vided or documented,” it has a wide range of definitions within the literature. This is largely because the financial incentives across programs and aspects under the coding
-
NHS reference costs: a history and cautionary note Health Economics Review (IF 2.118) Pub Date : 2023-11-22 Ben Amies-Cull, Ramon Luengo-Fernandez, Peter Scarborough, Jane Wolstenholme
Historically, the NHS did not routinely collect cost data, unlike many countries with private insurance markets. In 1998, for the first time the government mandated NHS trusts to submit estimates of their costs of service, known as reference costs. These have informed a wide range of health economic evaluations and important functions in the health service, such as setting prices. Reference costs are
-
Cost-utility analysis of Palbociclib + letrozole and ribociclib + letrozole versus Letrozole monotherapy in the first-line treatment of metastatic breast cancer in Iran using partitioned survival model Health Economics Review (IF 2.118) Pub Date : 2023-11-09 Ali Darvishi, Rajabali Daroudi, Ali Akbar Fazaeli
Palbociclib and Ribociclib are cyclin-dependent kinase 4/6 oral molecular inhibitors that have the potential to improve overall survival (OS), progression-free survival (PFS), and quality of life in patients with metastatic breast cancer (MBC). The objective of this study was to analyze the cost-utility of Palbociclib and Ribociclib in comparison with Letrozole monotherapy as the first-line treatment
-
Supply-side factors influencing demand for facility-based delivery in Tanzania: a multilevel analysis Health Economics Review (IF 2.118) Pub Date : 2023-11-06 Peter Binyaruka, Anna Foss, Abdullah Alibrahim, Nicholaus Mziray, Rachel Cassidy, Josephine Borghi
Improving access to facility-based delivery care has the potential to reduce maternal and newborn deaths across settings. Yet, the access to a health facility for childbirth remains low especially in low-income settings. To inform evidence-based interventions, more evidence is needed especially accounting for demand- and supply-side factors influencing access to facility-based delivery care. We aimed
-
Forecasting emergency department arrivals using INGARCH models Health Economics Review (IF 2.118) Pub Date : 2023-10-28 Juan C. Reboredo, Jose Ramon Barba-Queiruga, Javier Ojea-Ferreiro, Francisco Reyes-Santias
Forecasting patient arrivals to hospital emergency departments is critical to dealing with surges and to efficient planning, management and functioning of hospital emerency departments. We explore whether past mean values and past observations are useful to forecast daily patient arrivals in an Emergency Department. We examine whether an integer-valued generalized autoregressive conditional heteroscedastic
-
Correction: Economic burden of chronic migraine in OECD countries: a systematic review Health Economics Review (IF 2.118) Pub Date : 2023-10-25 Alyaa Eltrafi, Sunil Shrestha, Ali Ahmed, Hema Mistry, Vibhu Paudyal, Saval Khanal
Correction: Health Econ Rev 13, 43 (2023) https://doi.org/10.1186/s13561-023-00459-2 Following publication of the original article [1], the authors corrected the errors in the affiliations of Ali Ahmed, Hema Mistry, and Saval Khanal. Correct affiliations are as follows: Ali Ahmed • School of Pharmacy, Monash University Malaysia, Bandar Sunway, 47500, Malaysia. • Department of Pharmacy Practice, Riphah
-
Work accident effect on the use of psychotropic drugs: the case of benzodiazepines Health Economics Review (IF 2.118) Pub Date : 2023-10-23 Thomas Barnay, François-Olivier Baudot
A work accident constitutes a shock to health, likely to alter mental states and affect the use of psychotropic drugs. We focus on the use of benzodiazepines, which are a class of drugs commonly used to treat anxiety and insomnia. Prolonged use can lead to dependence. Our objective is to determine the extent to which work accidents lead to benzodiazepine use and overuse (i.e. exceedance of medical
-
Do public health expenditures affect maternal and child health in Madagascar? Health Economics Review (IF 2.118) Pub Date : 2023-10-18 Marilys Victoire Razakamanana, Voahirana Tantely Andrianatoandro, Tiarinisaina Olivier Ramiandrisoa
Previous studies have argued that the relationship between health expenditures and health outcomes is more significant among the poor than the non-poor. However, public spending alone does not improve health status. Quality of governance is considered not only as an important determinant of health outcomes but also of the efficiency of public expenditure on health. In low-income countries, barriers
-
Knowledge domain and emerging trends in multimorbidity and frailty research from 2003 to 2023: a scientometric study using citespace and VOSviewer Health Economics Review (IF 2.118) Pub Date : 2023-10-10 Penghong Deng, Chang Liu, Mingsheng Chen, Lei Si
Multimorbidity and frailty represent emerging global health burdens that have garnered increased attention from researchers over the past two decades. We conducted a scientometric analysis of the scientific literature on the coexistence of multimorbidity and frailty to assess major research domains, trends, and inform future lines of research. We systematically retrieved scientific publications on
-
Does patient behaviour drive physicians to practice defensive medicine? Evidence from a video experiment Health Economics Review (IF 2.118) Pub Date : 2023-09-22 Lotte Daniels, Wim Marneffe
By manipulating patients’ critical attitude in a video experiment, we examined whether physicians are more intended to perform defensive acts because of a higher perceived liability risk in Belgium. We assigned 85 practicing gynaecologists/obstetricians and orthopaedists randomly to four hypothetical video consultations, in which the patients show either a critical attitude (i.e., getting ahead of
-
Economic burden of chronic migraine in OECD countries: a systematic review Health Economics Review (IF 2.118) Pub Date : 2023-09-01 Alyaa Eltrafi, Sunil Shrestha, Ali Ahmed, Hema Mistry, Vibhu Paudyal, Saval Khanal
Chronic migraine (CM) is a significant neurological condition affecting a substantial portion of the global population. The economic burden of CM includes both direct healthcare costs and indirect costs resulting from productivity losses and intangible impacts on patients’ quality of life. However, there is limited research that comprehensively evaluates all cost components associated with CM, highlighting
-
Providing a model for financing the treatment costs during biological crises using the fiscal space development approach Health Economics Review (IF 2.118) Pub Date : 2023-08-01 Maryam Yaghoubi, Masoud Vahedi Idehlo, Parisa mehdizadeh, Mohammad Meskarpour Amiri
Expanding fiscal space for health can be defined as providing additional budgetary resources for health, which is highly important during biological crises. This study aimed to provide a model for financing the treatment costs during biological crises using the development of the fiscal space approach. This study employed a descriptive mixed-method design, consisting of three stages. In the first stage
-
Correction: Cost of peer mystery shopping to increase cultural competency in community clinics offering HIV/STI testing to young men who have sex with men: results from the get connected trial Health Economics Review (IF 2.118) Pub Date : 2023-07-26 Victoria L. Phillips, Ashley Xue, Marné Castillo, Dalia Santiago, Taylor Wimbly, Lisa B. Hightow-Weidman, Rob Stephenson, José A. Bauermeister
Correction: Health Econ Rev13, 34 (2023) https://doi.org/10.1186/s13561-023-00447-6 Following publication of the original article [1], the authors identified an error in the surname of Lisa B. Hightow-Weidman. The incorrect author name is: Lisa B. Hightow-Wideman. The correct author name is: Lisa B. Hightow-Weidman. The author group has been updated above and the original article [1] has been corrected
-
Sick and depressed? The causal impact of a diabetes diagnosis on depression Health Economics Review (IF 2.118) Pub Date : 2023-07-03 Alessio Gaggero, Joan Gil, Dolores Jiménez-Rubio, Eugenio Zucchelli
There is sparse evidence on the impact of health information on mental health as well as on the mechanisms governing this relationship. We estimate the causal impact of health information on mental health via the effect of a diabetes diagnosis on depression. We employ a fuzzy regression discontinuity design (RDD) exploiting the exogenous cut-off value of a biomarker used to diagnose type-2 diabetes
-
Out-of-pocket expenditure on community healthcare services at end-of-life among decedents from cardiovascular disease in six European countries and Israel Health Economics Review (IF 2.118) Pub Date : 2023-06-13 Aviad Tur-Sinai, Netta Bentur
Most people who develop chronic diseases, including cardiovascular disease (CVD), live in their homes in the community in their last year of life. Since cost-sharing is common in most countries, including those with universal health insurance, these people incur out of pocket expenditure (OOPE). The study aims to identify the prevalence and measure the size of OOPE among CVD decedents at end-of-life
-
The cost of implementing measles campaign in Nigeria: comparing the stand-alone and the integrated strategy Health Economics Review (IF 2.118) Pub Date : 2023-06-13 Anne Eudes Jean Baptiste, Jurjen Van der Schans, Samuel Bawa, Balcha Masresha, John Wagai, Joseph Oteri, Boubacar Dieng, Margaret Soyemi, Rufus Eshuchi, Yared G. Yehualashet, Oluwole Afolabi, Fiona Braka, André Bita, Eelko Hak
Effective integration, one of the seven strategic priorities of the Immunization Agenda 2030, can contribute to increasing vaccination coverage and efficiency. The objective of the study is to measure and compare input costs of “non-selective” measles vaccination campaign as a stand-alone strategy and when integrated with another vaccination campaign. We conducted a cost-minimization study using a
-
The impact of different care dependencies on people’s willingness to provide informal care: a discrete choice experiment in Germany Health Economics Review (IF 2.118) Pub Date : 2023-06-03 Lea de Jong, Torben Schmidt, Ann-Katrin Carstens, Kathrin Damm
Informal care provided by family members, friends, or neighbors is a major pillar in the German long-term care system. As the number of care-dependent older adults grow, ensuring their future care still relies on the willingness of family members, friends, or neighbors to assume the role of an informal caregiver. This study aimed to investigate the impact on people’s willingness to provide informal
-
Cost of peer mystery shopping to increase cultural competency in community clinics offering HIV/STI testing to young men who have sex with men: results from the get connected trial Health Economics Review (IF 2.118) Pub Date : 2023-06-02 Victoria L. Phillips, Ashley Xue, Marné Castillo, Dalia Santiago, Taylor Wimbly, Lisa B. Hightow-Wideman, Rob Stephenson, José A. Bauermeister
Cultural competency has been identified as a barrier to lesbian, gay, bisexual and transgender (LGBT) populations seeking care. Mystery shopping has been widely employed in the formal health care sector as a quality improvement (QI) tool to address specific client needs. The approach has had limited use in community-based organizations due in part to lack of knowledge and resource requirement concerns
-
Sustaining medical research – the role of trust and control Health Economics Review (IF 2.118) Pub Date : 2023-05-19 Michael John, Martin Kloyer, Steffen Fleßa
Medical research is increasingly interdisciplinary. However, not all projects are successful and cooperation is not always sustained beyond the end of funding. This study empirically assesses the effect of control and trust on the sustainability of interdisciplinary medical research in terms of its performance and satisfaction. The sample consists of 100 German publicly funded medical research collaborations
-
Global trends in the scientific research of the health economics: a bibliometric analysis from 1975 to 2022 Health Economics Review (IF 2.118) Pub Date : 2023-05-12 Liliana Barbu
Health science is evolving extremely rapidly at worldwide level. There is a large volume of articles about health economics that are published each year. The main purpose of this research is to explore health economics in the world's scholarly literature based on a scient metric analysis to outline the evolution of research in the field. The Web of Science repository was used to get the data (1975–2022)
-
Health outcome convergence in Africa: the roles of immunization and public health spending Health Economics Review (IF 2.118) Pub Date : 2023-05-10 Ariane Ephemia Ndzignat Mouteyica, Nicholas Ngepah
Reducing health outcomes disparities in Africa is a major concern for policymakers. Inter-country disparities in Africa is well documented. However, little is known about the accurate trajectory of these disparities over time. Thus, this paper investigates the convergence hypothesis in health outcomes in 40 African countries using data from the World Development Indicators. The study used panel data
-
Robotic-assisted surgery for prostatectomy – does the diffusion of robotic systems contribute to treatment centralization and influence patients’ hospital choice? Health Economics Review (IF 2.118) Pub Date : 2023-05-10 David Kuklinski, Justus Vogel, Cornelia Henschke, Christoph Pross, Alexander Geissler
Between 2008 and 2018, the share of robotic-assisted surgeries (RAS) for radical prostatectomies (RPEs) has increased from 3 to 46% in Germany. Firstly, we investigate if this diffusion of RAS has contributed to RPE treatment centralization. Secondly, we analyze if a hospital’s use of an RAS system influenced patients’ hospital choice. To analyze RPE treatment centralization, we use (bi-) annual hospital
-
Economic effects of healthy ageing: functional limitation, forgone wages, and medical and long-term care costs Health Economics Review (IF 2.118) Pub Date : 2023-05-10 Shohei Okamoto, Haruka Sakamoto, Kazuki Kamimura, Kohei Komamura, Erika Kobayashi, Jersey Liang
This study aims to estimate the potential economic benefits of healthy ageing by obtaining estimates of the economic losses generated by functional limitations among middle-aged and older people. Utilising two data sources retrieved from nationally representative samples of the Japanese people, we analysed the association between functional limitation and economic indicators, including labour market
-
Effects of the free healthcare policy on maternal and child health in Burkina Faso: a nationwide evaluation using interrupted time-series analysis Health Economics Review (IF 2.118) Pub Date : 2023-05-05 Patrick Gueswendé Ilboudo, Alain Siri
Burkina Faso has recently instituted a free healthcare policy for women and children under five. This comprehensive study examined the effects of this policy on the use of services, health outcomes, and removal of costs. Interrupted time-series regressions were used to investigate the effects of the policy on the use of health services and health outcomes. In addition, an analysis of household expenditures
-
Impact of diabetes diagnosis on dental care utilization: evidence from Finland Health Economics Review (IF 2.118) Pub Date : 2023-05-02 Mikko Nurminen, Hanna Rättö
Poor oral health is associated with many chronic diseases, including diabetes. As diabetes can worsen oral health and vice versa, care guidelines recommend that patients with diabetes maintain good oral health and have regular dental checkups. We analyzed the impact of receiving an initial type 2 diabetes diagnosis on dental care utilization. We used register data on residents aged over 25 in the city
-
Assessing the efficiency of health systems in achieving the universal health coverage goal: evidence from Sub-Saharan Africa Health Economics Review (IF 2.118) Pub Date : 2023-05-02 Kwadwo Arhin, Eric Fosu Oteng-Abayie, Jacob Novignon
Universal health coverage (UHC) is a major pathway to save many people from catastrophic and impoverishing healthcare spending and address the inequality in health and healthcare. The objective of this paper is to assess the efficiency with which health systems in sub-Saharan Africa (SSA) are utilizing healthcare resources to progress towards achieving the UHC goal by 2030. The study followed the guidelines
-
Differential costs for the non-adult ADHD population in Catalonia Health Economics Review (IF 2.118) Pub Date : 2023-04-22 Toni Mora, Jaume Puig-Junoy, Rowena Jacobs, Jordi Cid
Attention-Deficit/Hyperactivity Disorder (ADHD) is young children’s most common mental health disorder. We aim to provide causal estimates of the differential costs for the non-adult population with ADHD. We used longitudinal administrative data covering the non-adult population over five years and different healthcare providers (general practitioners, hospitalisations and emergency departments, visits
-
The role of Iran's context for the development of health technology assessment: challenges and solutions Health Economics Review (IF 2.118) Pub Date : 2023-04-20 Meysam Behzadifar, Masoud Behzadifar, Maryam Saran, Saeed Shahabi, Ahad Bakhtiari, Samad Azari, Nicola Luigi Bragazzi
Health technology assessment (HTA) is a comprehensive and structured evaluation that aims to analyze the potential impacts of health technologies, including medical devices, diagnostic tools, pharmaceuticals, and public health interventions. Its purpose is to provide policymakers with evidence-based information to inform decisions related to the utilization and implementation of these technologies
-
The fragile healthcare system in Lebanon: sounding the alarm about its possible collapse Health Economics Review (IF 2.118) Pub Date : 2023-04-04 Elie Bou Sanayeh, Carolla El Chamieh
Lebanon is currently facing a complex and multifaceted healthcare crisis. The country has been grappling with a severe financial crisis since 2019, which has been compounded by the social unrest, the devastating Beirut blast in 2020, and the ongoing coronavirus pandemic. Additionally, many hospitals in Lebanon are facing significant difficulties following the devaluation of the Lebanese currency, which
-
The role of risk preferences: voluntary health insurance in rural Tanzania Health Economics Review (IF 2.118) Pub Date : 2023-04-01 Alphoncina Kagaigai, Sverre Grepperud
Lower-middle-income countries (LMICs) have a common goal to achieve universal health coverage (UHC) through voluntary health insurance schemes. This is important to improve access to healthcare services and ensure financial protection for all by reducing out-of-pocket expenditures. This study aimed to examine the role of risk preferences on enrollment status (currently insured, previously insured,
-
Economic evaluation of strategies against coronavirus: a systematic review Health Economics Review (IF 2.118) Pub Date : 2023-03-18 Reyhane Izadi, Nahid Hatam, Fatemeh Baberi, Setareh Yousefzadeh, Abdosaleh Jafari
The COVID-19 outbreak was defined as a pandemic on 11 March 2020 by the World Health Organization. After that, COVID-19 has enormously influenced health systems around the world, and it has claimed more than 4.2 million deaths until July 2021. The pandemic has led to global health, social and economic costs. This situation has prompted a crucial search for beneficial interventions and treatments, but
-
Patient preferences for epilepsy treatment: a systematic review of discrete choice experimental studies Health Economics Review (IF 2.118) Pub Date : 2023-03-18 Sinaa Al-Aqeel, Reem Alotaiwi, Bushra Albugami
This review aimed to 1) identify and assess the quality of discrete choice experiments (DCEs) examining preferences related to epilepsy treatment; 2) summarize the attributes and attribute levels measured in these studies; 3) identify how researchers selected and developed these attributes; and 4) identify which attributes are most important for epilepsy patients. A systematic literature review using
-
The level of countries’ preparedness to health risks during Covid-19 and pre-pandemic: the differential response to health systems building blocks and socioeconomic indicators Health Economics Review (IF 2.118) Pub Date : 2023-03-14 Omar B. Da’ar, Farah Kalmey
The global health security (GHS) Index assesses countries’ level of preparedness to health risks. However, there is no evidence on how and whether the effects of health systems building blocks and socioeconomic indicators on the level of preparedness differ for low and high prepared countries. The aim of this study was to examine the contributions of health systems building blocks and socioeconomic
-
Statistical actuarial estimation of the Capitation Payment Unit from copula functions and deep learning: historical comparability analysis for the Colombian health system, 2015–2021 Health Economics Review (IF 2.118) Pub Date : 2023-02-24 Oscar Espinosa, Valeria Bejarano, Jeferson Ramos, Boris Martínez
The Capitation Payment Unit (CPU) financing mechanism constitutes more than 70% of health spending in Colombia, with a budget allocation of close to 60 trillion Colombian pesos for the year 2022 (approximately 15.7 billion US dollars). This article estimates actuarially, using modern techniques, the CPU for the contributory regime of the General System of Social Security in Health in Colombia, and
-
The intangible costs of overweight and obesity in Germany Health Economics Review (IF 2.118) Pub Date : 2023-02-21 Fan Meng, Peng Nie, Alfonso Sousa-Poza
Previous literature documents the direct and indirect economic costs of obesity, yet none has attempted to quantify the intangible costs of obesity. This study focuses on quantifying the intangible costs of one unit body mass index (BMI) increase and being overweight and obese in Germany. By applying a life satisfaction-based compensation value analysis to 2002–2018 German Socio-Economic Panel Survey
-
Cost-effectiveness in unstable economies: the case of sacubitril/valsartan in heart failure with reduced ejection fraction in Argentina Health Economics Review (IF 2.118) Pub Date : 2023-02-18 Mariano A. Giorgi, Carlos P. Boissonnet, Paula Soledad Luque, Jimena Piastrella, Carlos Porley, Fernanda Ditata, Sergio Volman
Sacubitril/valsartan (an Angiotensin receptor-neprilysin inhibitor—ARNI) is one of the cornerstones in the management of patients with heart failure with reduced ejection fraction (HFrEF) having demonstrated significant reductions in both mortality and hospitalisations as compared with enalapril. It proved to be a cost-effective treatment in many countries with stable economies. In Argentina, a country
-
The economic impact of anastomotic leak after colorectal cancer surgery Health Economics Review (IF 2.118) Pub Date : 2023-02-16 Blas Flor-Lorente, José Francisco Noguera-Aguilar, Salvadora Delgado-Rivilla, José María García-González, Marcos Rodriguez-Martín, Laura Salinas-Ortega, Miguel Ángel Casado, María Álvarez
To determine the economic impact of the incremental consumption of resources for the diagnosis and treatment of anastomotic leak (AL) in patients after resection with anastomosis for colorectal cancer compared to patients without AL on the Spanish health system. This study included a literature review with parameters validated by experts and the development of a cost analysis model to estimate the
-
Should we adjust health expenditure for age structure on health systems efficiency? A worldwide analysis Health Economics Review (IF 2.118) Pub Date : 2023-02-13 João Vasco Santos, Filipa Santos Martins, Joana Pestana, Júlio Souza, Alberto Freitas, Jonathan Cylus
Healthcare expenditure, a common input used in health systems efficiency analyses is affected by population age structure. However, while age structure is usually considered to adjust health system outputs, health expenditure and other inputs are seldom adjusted. We propose methods for adjusting Health Expenditure per Capita (HEpC) for population age structure on health system efficiency analyses and
-
The lack of specialized pediatric cardiac surgeons in Lebanon: a humanitarian catastrophe Health Economics Review (IF 2.118) Pub Date : 2023-02-11 Jana Zeineddine, Carolla El Chamieh, Elie Bou Sanayeh
Congenital heart disease (CHD) is a major public health concern, as it is the most common birth defect and the leading cause of death in the first year of life if adequate surgical interventions were not provided. Unfortunately, in Lebanon, a country that has been assailed by devastating social and economic crises, many specialized Lebanese pediatric heart surgeons fled abroad to secure more stable
-
Predicting high health-cost users among people with cardiovascular disease using machine learning and nationwide linked social administrative datasets Health Economics Review (IF 2.118) Pub Date : 2023-02-04 Nhung Nghiem, June Atkinson, Binh P. Nguyen, An Tran-Duy, Nick Wilson
To optimise planning of public health services, the impact of high-cost users needs to be considered. However, most of the existing statistical models for costs do not include many clinical and social variables from administrative data that are associated with elevated health care resource use, and are increasingly available. This study aimed to use machine learning approaches and big data to predict
-
An assessment of out of pocket payments in public sector health facilities under the free maternal healthcare policy in Ghana Health Economics Review (IF 2.118) Pub Date : 2023-01-28 Maxwell Tii Kumbeni, Agani Afaya, Paschal Awingura Apanga
The free maternal healthcare policy was introduced in Ghana in 2008 under the national health insurance scheme as a social intervention to improve access to maternal health services. This study investigated the prevalence of out of pocket (OOP) payment among pregnant women with valid national health insurance who sought skilled delivery services at public sector health facilities in Ghana. The study
-
Approximating the influence of external factors on the technical efficiency score of hospital care: evidence from the federal states of Germany Health Economics Review (IF 2.118) Pub Date : 2023-01-25 Iveta Vrabková, Sabrina Lee
A good health care system and, especially, the provision of efficient hospital care are the goals of national and regional health policies. However, the scope of general hospital care in the 16 federal states in Germany varies considerably from region to region. The objectives of this paper are to evaluate the technical efficiencies of all general hospitals of the 16 federal states for the period from
-
Correction: Transcatheter aortic valve implantation against conventional aortic valve replacement surgery in high-risk patients with aortic stenosis; a cost-effectiveness analysis Health Economics Review (IF 2.118) Pub Date : 2023-01-20 Hesam Ghiasvand, Shiva Khaleghparast, Naser Kachoueian, Kourosh Tirgarfakheri, Meysam Mortazian, Yaser Toloueitabar, Farhad Gorjipour, Seyran Naghdi
Correction: Health Econ Rev 13, 1 (2023) https://doi.org/10.1186/s13561-022-00411-w Following publication of the original article [1], the authors would like to correct the statement in Ethics approval and consent to participate section for the reason that the ethics code issuer is a Center that is affiliated with the Iran University of Medical Sciences, and not the University itself. The statement
-
Incentivizing COVID-19 vaccination among racial/ethnic minority adults in the United States: $209 per dose could convince the hesitant Health Economics Review (IF 2.118) Pub Date : 2023-01-11 Chen, Kevin, Wilson-Barthes, Marta, Harris, Jeffrey E., Galárraga, Omar
More than two years into the coronavirus disease (COVID-19) pandemic, it remains unclear whether financial incentives can reduce vaccine hesitancy and improve uptake among key unvaccinated populations. This study estimated the willingness of racial/ethnic minority adults in the United States to accept financial incentives for COVID-19 vaccination and the minimum amount needed to vaccinate a sufficiently
-
Correction: Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in Japan Health Economics Review (IF 2.118) Pub Date : 2023-01-11 Takumoto, Yuki, Sasahara, Yuriko, Narimatsu, Hiroto, Murata, Tatsunori, Akazawa, Manabu
Correction: Health Econ Rev 12, 63 (2022) https://doi.org/10.1186/s13561-022-00413-8 Following publication of the original article [1], the authors identified errors in the names of all authors. The given name and family name were erroneously transposed, and the given name of “Hiroto Narimatsu” was incorrectly listed as “Hirohito”. The author group has been updated above and the original article [1]